Aptevo Therapeutics Launches New 3000 IU IXINITY Assay Offering Enhanced User Experience and Improved Convenience for Hemophilia B Patients GlobeNewswire
Expands Options for Patients with Potential for. Reduced Reconstitution Time and Infusion Volume. SEATTLE, June 25, 2019 (GLOBE NEWSWIRE) -- Aptevo ...
No comments:
Post a Comment